Publication

Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data

QSP modeling reveals patient-specific factors driving CAR T-cell response and relapse in multiple myeloma, with…

Certara2026 年 7 月 20 日

On-Demand Webinar

Expert Q&A: Identify Winning Biotherapeutics in Early Discovery

Watch this on-demand Q&A on using mechanistic modeling to assess feasibility and prioritize biotherapeutic candidates…

Certara2026 年 7 月 17 日

Webinar

Integrated mechanistic modeling approaches in oncology drug development

Certara2026 年 7 月 8 日

Publication

Review: application and opportunities for machine learning and artificial intelligence in preclinical immunogenicity risk assessment

This review explores how artificial intelligence (AI), machine learning (ML), and quantitative systems pharmacology (QSP)…

Certara2026 年 6 月 2 日

On-Demand Webinar

The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators

Learn how PBPK and QSP modeling support regulatory confidence, accelerate drug development, and align with…

Certara2026 年 5 月 26 日

Poster

借助 QSP 推进体内 CAR-T 疗法

Learn how QSP modeling improves first-in-human dose selection for CAR-T therapies, enabling better translation and…

Certara2026 年 5 月 12 日

Video

Certara IQ™ 演示视频

Watch a short demo of Certara IQ™, a QSP platform for modeling, simulation, and analysis.…

Certara2026 年 5 月 12 日

Publication

Understanding quantitative effects of anti-amyloid therapies on tau biomarkers and functional outcome

QSP modeling reveals how anti-amyloid therapies impact tau biomarkers and cognitive outcomes in Alzheimer’s disease.

Certara2026 年 5 月 4 日

Poster

Modeling CAR-T Outcomes in Multiple Myeloma

Learn how QSP modeling predicts CAR-T therapy outcomes, identifies patient-specific response drivers, and supports multi-antigen…

Certara2026 年 5 月 4 日

Poster

Modeling T-cell Exhaustion in Immunotherapy

Discover how QSP modeling predicts T-cell exhaustion, relapse risk, and optimal dosing strategies for T-cell…

Certara2026 年 5 月 4 日

Certara Products – Certara IQ

Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data

Expert Q&A: Identify Winning Biotherapeutics in Early Discovery

Integrated mechanistic modeling approaches in oncology drug development

Review: application and opportunities for machine learning and artificial intelligence in preclinical immunogenicity risk assessment

The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators

借助 QSP 推进体内 CAR-T 疗法

Certara IQ™ 演示视频

Understanding quantitative effects of anti-amyloid therapies on tau biomarkers and functional outcome

Modeling CAR-T Outcomes in Multiple Myeloma

Modeling T-cell Exhaustion in Immunotherapy

订阅时事通讯

快捷链接

解决方案

联系我们